Cargando…
As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State
The COVID-19 pandemic has caused more than 448 million cases and 6 million deaths worldwide to date. Omicron is now the dominant SARS-CoV-2 variant, making up more than 90% of cases in countries reporting sequencing data. As the pandemic continues into its third year, continued testing is a strategi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121917/ https://www.ncbi.nlm.nih.gov/pubmed/35602143 http://dx.doi.org/10.3389/fpubh.2022.883066 |
_version_ | 1784711241540829184 |
---|---|
author | Miller, Melissa B. Ooi, Eng Eong Rhoads, Daniel D. Kulldorff, Martin Anderson, Danielle E. Lee, Hyukmin Gupta, Sunetra Mel, Krajden |
author_facet | Miller, Melissa B. Ooi, Eng Eong Rhoads, Daniel D. Kulldorff, Martin Anderson, Danielle E. Lee, Hyukmin Gupta, Sunetra Mel, Krajden |
author_sort | Miller, Melissa B. |
collection | PubMed |
description | The COVID-19 pandemic has caused more than 448 million cases and 6 million deaths worldwide to date. Omicron is now the dominant SARS-CoV-2 variant, making up more than 90% of cases in countries reporting sequencing data. As the pandemic continues into its third year, continued testing is a strategic and necessary tool for transitioning to an endemic state of COVID-19. Here, we address three critical topics pertaining to the transition from pandemic to endemic: defining the endemic state for COVID-19, highlighting the role of SARS-CoV-2 testing as endemicity is approached, and recommending parameters for SARS-CoV-2 testing once endemicity is reached. We argue for an approach that capitalizes on the current public health momentum to increase capacity for PCR-based testing and whole genome sequencing to monitor emerging infectious diseases. Strategic development and utilization of testing, including viral panels in addition to vaccination, can keep SARS-CoV-2 in a manageable endemic state and build a framework of preparedness for the next pandemic. |
format | Online Article Text |
id | pubmed-9121917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91219172022-05-21 As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State Miller, Melissa B. Ooi, Eng Eong Rhoads, Daniel D. Kulldorff, Martin Anderson, Danielle E. Lee, Hyukmin Gupta, Sunetra Mel, Krajden Front Public Health Public Health The COVID-19 pandemic has caused more than 448 million cases and 6 million deaths worldwide to date. Omicron is now the dominant SARS-CoV-2 variant, making up more than 90% of cases in countries reporting sequencing data. As the pandemic continues into its third year, continued testing is a strategic and necessary tool for transitioning to an endemic state of COVID-19. Here, we address three critical topics pertaining to the transition from pandemic to endemic: defining the endemic state for COVID-19, highlighting the role of SARS-CoV-2 testing as endemicity is approached, and recommending parameters for SARS-CoV-2 testing once endemicity is reached. We argue for an approach that capitalizes on the current public health momentum to increase capacity for PCR-based testing and whole genome sequencing to monitor emerging infectious diseases. Strategic development and utilization of testing, including viral panels in addition to vaccination, can keep SARS-CoV-2 in a manageable endemic state and build a framework of preparedness for the next pandemic. Frontiers Media S.A. 2022-04-28 /pmc/articles/PMC9121917/ /pubmed/35602143 http://dx.doi.org/10.3389/fpubh.2022.883066 Text en Copyright © 2022 Miller, Ooi, Rhoads, Kulldorff, Anderson, Lee, Gupta and Mel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Miller, Melissa B. Ooi, Eng Eong Rhoads, Daniel D. Kulldorff, Martin Anderson, Danielle E. Lee, Hyukmin Gupta, Sunetra Mel, Krajden As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State |
title | As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State |
title_full | As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State |
title_fullStr | As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State |
title_full_unstemmed | As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State |
title_short | As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State |
title_sort | as omicron takes hold and other new variants arise, covid-19 testing remains the universally agreed tool to effect transition from pandemic to endemic state |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121917/ https://www.ncbi.nlm.nih.gov/pubmed/35602143 http://dx.doi.org/10.3389/fpubh.2022.883066 |
work_keys_str_mv | AT millermelissab asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT ooiengeong asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT rhoadsdanield asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT kulldorffmartin asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT andersondaniellee asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT leehyukmin asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT guptasunetra asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate AT melkrajden asomicrontakesholdandothernewvariantsarisecovid19testingremainstheuniversallyagreedtooltoeffecttransitionfrompandemictoendemicstate |